Share >  
Share
Share on Tumblr

Surya Pharma Result

News »

   latest by relevance
Pfizer plans to launch 15 new products in FY13
May 22, 2012 at 14:33 | Source: CNBC-TV18
Pharma major Pfizer registered a net profit of Rs 48.10 crore in the fourth quarter of FY12 in comparison to Rs 63.14 crore in the corresponding quarter last fiscal.
Dishman Pharma expects 25% growth in FY13
May 15, 2012 at 16:33 | Source: CNBC-TV18
Dishman Pharmaceuticals posted a 13.24% topline growth in the fourth quarter of FY12 and reported a consolidated net profit of Rs 312.94 million for the quarter ended 31 March, 2012, up 37.30% from Rs 227.92 million in the corresponding quarter last year.
Dr Reddy's Q4 net up lower-than-expected 2.5%; shrs fall
May 11, 2012 at 14:30 | Source: Moneycontrol.com
Dr Reddy's Laboratories disappointed the street as fourth quarter consolidated net profit rose lower-than-expected 2.5% year-on-year to Rs 342.70 crore. The pharma major had impairment loss on intangible assets of Rs 104 crore in the quarter.
Lupin Q4 cons net profit declines 31% as tax expenses rise
May 10, 2012 at 15:46 | Source: Moneycontrol.com
Pharma company Lupin's fourth quarter consolidated net profit declined 31% year-on-year to Rs 156 crore due to higher tax expenses.
Ranbaxy Q1 jumps 300%, What are analysts saying?
May 10, 2012 at 12:34 | Source: Moneycontrol.com
Pharma major Ranbaxy on Wednesday beat street estimates with a four-fold year-on-year jump in first quarter net profit at Rs 1,247 crore. However, many analysts were unimpressed on the results, which were boosted mainly by forex gains and strong sales of its copy of cholesterol lowering drug Lipitor.
Ranbaxy Q1 net jumps 310%; to set up new plant in Nigeria
May 09, 2012 at 17:39 | Source: Moneycontrol.com
Pharma major Ranbaxy on Wednesday beat street estimates with a four-fold year-on-year increase in first quarter net profit at Rs 1,247 crore, helped by strong sales including that of its cholesterol lowering drug Atorvastatin in the US market, and forex gains.

Videos »
Pfizer plans to launch 15 new products in FY13
Dishman Pharma expects 25% growth in FY13
Auto, pharma to take lead if market goes up: Vishal Malkan
Surya Pharma shuts down two plants on capital crisis
Experts warn mkt may slip more: So, which stocks to bet now
more »

Photos »

  /  

Follow moneycontrol.com

Facebook Twitter Google Plus RSS Wap SMS SMS Alert iPad iPhone Blackberry OVI Android Window